Search

Current filters:


Use filters to refine the search results.

Results 11-20 of 22 (Search time: 0.007 seconds).
Item hits:
PreviewIssue dateOnline publication dateTitleAuthor(s)
healthrelated_quality_of_life-20220805150847806.pdf.jpg20219-Aug-2022Health-related quality of life in patients with autoimmune hepatitisMichel, Maurice; Spinelli, Francesca; Grambihler, Annette; Labenz, Christian; Nagel, Michael; Kaps, Leonard; Huber, Yvonne; Galle, Peter R.; Wörns, Marcus-Alexander; Schattenberg, Jörn M.
burden_of_depression_and_anxi-20220822122501994.pdf.jpg202223-Aug-2022Burden of depression and anxiety disorders per disease codes in patients with lymphoma in GermanyTilch, Marie-Kristin; Galle, Peter R.; Schattenberg, Jörn M.; Kostev, Karel; Labenz, Christian
59415.pdf.jpg201911-Nov-2019Cardiovascular risk categories in patients with nonalcoholic fatty liver disease and the role of low-density lipoprotein cholesterolLabenz, Christian; Prochaska, Jürgen H.; Huber, Yvonne; Nagel, Michael; Straub, Beate; Wild, Philipp; Galle, Peter R.; Schattenberg, Jörn
58508.pdf.jpg201817-Oct-2018The immune contexture of hepatocellular carcinoma predicts clinical outcomeFoerster, Friedrich; Hess, Moritz; Gerhold-Ay, Aslihan; Marquardt, Jens; Becker, Diana; Galle, Peter R.; Schuppan, Detlef; Binder, Harald; Bockamp, Ernesto
michel_maurice-the_role_of_p5-20210723162504858.pdf.jpg20212-Aug-2021The role of p53 dysfunction in colorectal cancer and its implication for therapyMichel, Maurice; Kaps, Leonard; Maderer, Annett; Galle, Peter R.; Moehler, Markus
mähringer-kunz_aline-predicting_sur-20210826101204684.pdf.jpg202026-Aug-2021Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network : a pilot studyMähringer-Kunz, Aline; Wagner, Franziska; Hahn, Felix; Weinmann, Arndt; Brodehl, Sebastian; Schotten, Sebastian; Hinrichs, Jan B.; Düber, Christoph; Galle, Peter R.; Pinto dos Santos, Daniel; Kloeckner, Roman
labenz_christian-incident_demen-20210826121540456.pdf.jpg202126-Aug-2021Incident dementia in elderly patients with nonalcoholic fatty liver disease in GermanyLabenz, Christian; Kostev, Karel; Kaps, Leonard; Galle, Peter R.; Schattenberg, Jörn M.
kloeckner_roman-survival_predi-20210416121106975.pdf.jpg20203-May-2021Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy : a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imagingHahn, Felix; Müller, Lukas; Jungmann, Florian; Mähringer‑Kunz, Aline; Tanyildizi, Yasemin; Düber, Christoph; Galle, Peter R.; Weinmann, Arndt; Kloeckner, Roman
ramucirumab_in_patients_with_-20220902173054571.pdf.jpg20217-Sep-2022Ramucirumab in patients with previously treated advanced hepatocellular carcinoma : impact of liver disease aetiologyGalle, Peter R.; Kudo, Masatoshi; Llovet, Josep M.; Finn, Richard S.; Karwal, Mark; Pezet, Denis; Kim, Tae-You; Yang, Tsai-Sheng; Lonardi, Sara; Tomasek, Jiri; Phelip, Jean-Marc; Touchefeu, Yann; Koh, Su-Jin; Stirnimann, Guido; Liang, Kun; Ogburn, Kenyon D.; Wang, Chunxiao; Abada, Paolo; Widau, Ryan C.; Zhu, Andrew X.
evaluation_of_a_laboratorybas-20220822134023960.pdf.jpg202123-Aug-2022Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admissionHäuser, Friederike; Sprinzl, Martin F.; Dreis, Kim J.; Renzaho, Angelique; Youhanen, Simon; Kremer, Wolfgang M.; Podlech, Jürgen; Galle, Peter R.; Lackner, Karl J.; Rossmann, Heidi; Lemmermann, Niels A.